As filed with the Securities and Exchange Commission on February 23, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Guardant Health, Inc.
(Exact name of Registrant as specified in its charter)
|
|
|
Delaware |
|
45-4139254 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification Number) |
|
|
3100 Hanover Street
Palo Alto, California |
|
94304 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
2018 Incentive Award Plan
2018 Employee Stock Purchase Plan
(Full Title of the Plan)
John Saia
Chief Legal
Officer and Corporate Secretary
3100 Hanover Street
Palo Alto, California, 94304
(855) 698-8887
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Andrew Thorpe, Esq.
Elena Vespoli, Esq.
Gunderson Dettmer Stough Villeneuve
Franklin & Hachigian, LLP
One Bush Plaza
Suite
1200
San Francisco, California 94104
Tel: (415) 978-9803
Fax: (415) 978-9806
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐